![Mert Aktar](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mert Aktar
Directeur/Membre du Conseil chez
KYVERNA THERAPEUTICS, INC.
Fortune : 185 114 $ au 31/05/2026
Profil
Mert Aktar is currently Director at ReAlta Life Sciences, Inc. since 2024, Independent Director at Kyverna Therapeutics, Inc. since 2024, and Director at UCLA Technology Development Group since 2022.
Formerly, Mr. Aktar was Head of Business & Corporate Development at Cogent Biosciences, Inc. from 2019 to 2020.
Education includes graduate studies at Tufts University, undergraduate studies at Worcester Polytechnic Institute, and an MBA from MIT Sloan School of Management.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 27/05/2026 | 21 727 ( 0,04 % ) | 185 114 $ | 31/05/2026 |
Postes actifs de Mert Aktar
| Sociétés | Poste | Début |
|---|---|---|
| KYVERNA THERAPEUTICS, INC. | Directeur/Membre du Conseil | 20/10/2024 |
ReAlta Life Sciences, Inc.
 ReAlta Life Sciences, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which develops novel class of drugs with dual-targeting therapeutic capabilities | Directeur/Membre du Conseil | 01/01/2024 |
Ucla Technology Development Group
 Ucla Technology Development Group Miscellaneous Commercial ServicesCommercial Services Engages in provision of intellectual property rights | Directeur/Membre du Conseil | 01/11/2022 |
Anciens postes connus de Mert Aktar
| Sociétés | Poste | Fin |
|---|---|---|
| COGENT BIOSCIENCES, INC. | Corporate Officer/Principal | 01/03/2020 |
Formation de Mert Aktar
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
5
Relations au 1er degré
7
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 7 |
|---|---|
Cogent Biosciences, Inc.
 Cogent Biosciences, Inc. BiotechnologyHealth Technology Discovers and develops new cellular immunotherapies for cancer | Health Technology |
Tufts University
 Tufts University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Worcester Polytechnic Institute
 Worcester Polytechnic Institute Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
MIT Sloan School of Management
 MIT Sloan School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ucla Technology Development Group
Ucla Technology Development Group Miscellaneous Commercial ServicesCommercial Services Engages in provision of intellectual property rights | Commercial Services |
ReAlta Life Sciences, Inc.
ReAlta Life Sciences, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which develops novel class of drugs with dual-targeting therapeutic capabilities | Health Technology |
Kyverna Therapeutics, Inc.
 Kyverna Therapeutics, Inc. BiotechnologyHealth Technology Operates as a cell therapy company which develops treatments and potential cures for serious autoimmune diseases | Health Technology |
